Link:
Publication:
Georgia Health News
Category:
Specialty Tiers
Article Date:
Monday, September 12, 2011
"Seven years ago, Ed Levitt received what he considered a death sentence.
He was diagnosed with Stage 4 lung cancer. For a nonsmoker who had seemed “fit as a fiddle,’’ the diagnosis came as a shock.
He had worked for a Fortune 500 company, and he believes the chemicals involved in his work led to his lung cancer.
Levitt, of Acworth, began taking a drug called Iressa, a so-called “biologic’’ drug. Biologics are complex mixtures made from living organisms. Unlike other drugs, they are not chemically synthesized.
The good news for Levitt was that the drug therapy shrank the tumors in his body, so that his lung cancer is under control for now.
The bad news was the price..."
Like Us on Facebook
Follow Us on Twitter